Live feed
·
NEWSReleasevia Quantisnow
Lexaria Bioscience Corp. logo

Primary Endpoint Successfully Achieved in Lexaria's Phase 1b Study GLP-1-H24-4

ByQuantisnow·Wall Street's wire, on your screen.
LEXX· Lexaria Bioscience Corp.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LEXX (Lexaria Bioscience Corp.) and more on Quantisnow.